Century Therapeutics (IPSC)
(Delayed Data from NSDQ)
$0.48 USD
-0.03 (-5.88%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $0.49 +0.01 (2.68%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Century Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
IPSC 0.48 -0.03(-5.88%)
Will IPSC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IPSC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IPSC
All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock
IPSC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates
Other News for IPSC
Fell Below 20 Day Moving Average appears for IPSC after 5.88% move
Is IPSC set to rally? Crossed Above 20 Day Moving Average shows up after gaining 3.07%
IPSC forms 20 Day Moving Average Resistance on September 17
IPSC forms Doji - Bullish? on September 16
Is IPSC positioned for a breakdown? 20 Day Moving Average Resistance shows up after slipping 0.72%